BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 11438699)

  • 1. A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P.
    Schenck A; Bardoni B; Moro A; Bagni C; Mandel JL
    Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8844-9. PubMed ID: 11438699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligomerization properties of fragile-X mental-retardation protein (FMRP) and the fragile-X-related proteins FXR1P and FXR2P.
    Tamanini F; Van Unen L; Bakker C; Sacchi N; Galjaard H; Oostra BA; Hoogeveen AT
    Biochem J; 1999 Nov; 343 Pt 3(Pt 3):517-23. PubMed ID: 10527928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C terminus of fragile X mental retardation protein interacts with the multi-domain Ran-binding protein in the microtubule-organising centre.
    Menon RP; Gibson TJ; Pastore A
    J Mol Biol; 2004 Oct; 343(1):43-53. PubMed ID: 15381419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology of the fragile X mental retardation protein, an RNA-binding protein.
    Khandjian EW
    Biochem Cell Biol; 1999; 77(4):331-42. PubMed ID: 10546896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport kinetics of FMRP containing the I304N mutation of severe fragile X syndrome in neurites of living rat PC12 cells.
    Schrier M; Severijnen LA; Reis S; Rife M; van't Padje S; van Cappellen G; Oostra BA; Willemsen R
    Exp Neurol; 2004 Oct; 189(2):343-53. PubMed ID: 15380484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N-terminus of the fragile X mental retardation protein contains a novel domain involved in dimerization and RNA binding.
    Adinolfi S; Ramos A; Martin SR; Dal Piaz F; Pucci P; Bardoni B; Mandel JL; Pastore A
    Biochemistry; 2003 Sep; 42(35):10437-44. PubMed ID: 12950170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of mouse YB1/p50 as a component of the FMRP-associated mRNP particle.
    Ceman S; Nelson R; Warren ST
    Biochem Biophys Res Commun; 2000 Dec; 279(3):904-8. PubMed ID: 11162447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative splicing in the murine and human FXR1 genes.
    Kirkpatrick LL; McIlwain KA; Nelson DL
    Genomics; 1999 Jul; 59(2):193-202. PubMed ID: 10409431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragile X syndrome, the Fragile X related proteins, and animal models.
    Hoogeveen AT; Willemsen R; Oostra BA
    Microsc Res Tech; 2002 May; 57(3):148-55. PubMed ID: 12112450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragile X mental retardation protein levels increase following complex environment exposure in rat brain regions undergoing active synaptogenesis.
    Irwin SA; Christmon CA; Grossman AW; Galvez R; Kim SH; DeGrush BJ; Weiler IJ; Greenough WT
    Neurobiol Learn Mem; 2005 May; 83(3):180-7. PubMed ID: 15820853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragile X mental retardation: misregulation of protein synthesis in the developing brain?
    Feng Y
    Microsc Res Tech; 2002 May; 57(3):145-7. PubMed ID: 12112449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular phenotype of Fragile X syndrome: FMRP, FXRPs, and protein targets.
    Kaufmann WE; Cohen S; Sun HT; Ho G
    Microsc Res Tech; 2002 May; 57(3):135-44. PubMed ID: 12112448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif.
    Schaeffer C; Bardoni B; Mandel JL; Ehresmann B; Ehresmann C; Moine H
    EMBO J; 2001 Sep; 20(17):4803-13. PubMed ID: 11532944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse.
    Bakker CE; de Diego Otero Y; Bontekoe C; Raghoe P; Luteijn T; Hoogeveen AT; Oostra BA; Willemsen R
    Exp Cell Res; 2000 Jul; 258(1):162-70. PubMed ID: 10912798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fragile X mental retardation protein has nucleic acid chaperone properties.
    Gabus C; Mazroui R; Tremblay S; Khandjian EW; Darlix JL
    Nucleic Acids Res; 2004; 32(7):2129-37. PubMed ID: 15096575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nuclear role for the Fragile X mental retardation protein.
    Fridell RA; Benson RE; Hua J; Bogerd HP; Cullen BR
    EMBO J; 1996 Oct; 15(19):5408-14. PubMed ID: 8895584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of FMRP with ribosomal precursor particles in the nucleolus.
    Willemsen R; Bontekoe C; Tamanini F; Galjaard H; Hoogeveen A; Oostra B
    Biochem Biophys Res Commun; 1996 Aug; 225(1):27-33. PubMed ID: 8769090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FMRP interferes with the Rac1 pathway and controls actin cytoskeleton dynamics in murine fibroblasts.
    Castets M; Schaeffer C; Bechara E; Schenck A; Khandjian EW; Luche S; Moine H; Rabilloud T; Mandel JL; Bardoni B
    Hum Mol Genet; 2005 Mar; 14(6):835-44. PubMed ID: 15703194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fragile X mental retardation protein interacts with human NDK/Nm23-H2].
    Lou R; Mei PC; Gong JY; Zhu N; Kou ZH; Wu GY; Shen Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):580-4. PubMed ID: 12901102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A distinct FMRP polysomal population at an advanced stage of mammalian erythropoiesis.
    Beaulieu MA
    Biochem Biophys Res Commun; 2000 Aug; 275(2):608-10. PubMed ID: 10964711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.